Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAZR
2201
DELISTED
Luminar Technologies
LAZR
| $321K | ﹤0.01% |
6,341
-7
| -0.1% | -$348 |
|
|
ACRE
2202
Ares Commercial Real Estate
ACRE
$239M
| $320K | ﹤0.01% |
30,894
-42
| -0.1% | -$413 |
|
|
CHUY
2203
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $319K | ﹤0.01% |
8,336
-19
| -0.2% | -$665 |
|
|
NVRO
2204
DELISTED
NEVRO CORP.
NVRO
| $319K | ﹤0.01% |
14,804
-28
| -0.2% | -$500 |
|
2205
ChargePoint
CHPT
$142M
| $319K | ﹤0.01% |
6,823
-7
| -0.1% | -$392 |
|
2206
Arcturus Therapeutics
ARCT
$168M
| $318K | ﹤0.01% |
10,097
-19
| -0.2% | -$452 |
|
2207
Pliant Therapeutics
PLRX
$65.6M
| $317K | ﹤0.01% |
17,525
-26
| -0.1% | -$395 |
|
|
VZIO
2208
DELISTED
VIZIO Holding Corp.
VZIO
| $317K | ﹤0.01% |
41,152
-36
| -0.1% | -$225 |
|
|
INN
2209
Summit Hotel Properties
INN
$748M
| $317K | ﹤0.01% |
47,096
-86
| -0.2% | -$529 |
|
2210
IMAX
IMAX
$2.61B
| $315K | ﹤0.01% |
20,968
| – | – |
|
2211
Argan
AGX
$8.13B
| $315K | ﹤0.01% |
6,723
-11
| -0.2% | -$502 |
|
2212
Opko Health
OPK
$993M
| $314K | ﹤0.01% |
208,449
-345
| -0.2% | -$499 |
|
2213
Enviri
NVRI
$624M
| $314K | ﹤0.01% |
34,825
-63
| -0.2% | -$429 |
|
2214
Community Trust Bancorp
CTBI
$1.42B
| $314K | ﹤0.01% |
7,143
-13
| -0.2% | -$513 |
|
2215
Simulations Plus
SLP
$370M
| $313K | ﹤0.01% |
6,995
-13
| -0.2% | -$515 |
|
2216
Wolverine World Wide
WWW
$1.64B
| $313K | ﹤0.01% |
35,232
-63
| -0.2% | -$536 |
|
2217
Aehr Test Systems
AEHR
$2.51B
| $313K | ﹤0.01% |
11,790
-17
| -0.1% | -$496 |
|
|
OPTU
2218
Optimum Communications Inc
OPTU
$290M
| $313K | ﹤0.01% |
96,097
+564
| +0.6% | +$1.48K |
|
2219
Ethan Allen Interiors
ETD
$583M
| $312K | ﹤0.01% |
9,782
-18
| -0.2% | -$516 |
|
2220
Lifestance Health
LFST
$4.1B
| $311K | ﹤0.01% |
39,665
-165
| -0.4% | -$1.06K |
|
2221
Gray Television
GTN
$417M
| $311K | ﹤0.01% |
34,742
-66
| -0.2% | -$491 |
|
2222
Credicorp
BAP
$32B
| $311K | ﹤0.01% |
2,079
| – | – |
|
2223
Editas Medicine
EDIT
$413M
| $309K | ﹤0.01% |
30,524
-65
| -0.2% | -$571 |
|
2224
Artivion
AORT
$1.34B
| $308K | ﹤0.01% |
17,239
-31
| -0.2% | -$482 |
|
2225
Aecom
ACM
$9.22B
| $306K | ﹤0.01% |
3,315
-110
| -3% | -$9.34K |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.